- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Study Urges Lung Cancer Trials to Include Survivors
The study, published in the Journal of the National Cancer Institute, found that having a prior cancer diagnosis did not affect outcomes among the patients with advanced lung cancer, which means these patients should be allowed to take part in clinical trials of new lung cancer treatments.
Cancer survivors should not be excluded from clinical trials of new lung cancer treatments, according to a study that challenges common practice.
Researchers analyzed data from nearly 103,000 people older than 65 who were diagnosed with advanced lung cancer between 1992 and 2009. Of those patients, nearly 15% had survived previous cancers, including prostate, breast and gastrointestinal cancers.
Those who had survived an earlier cancer had 10% better overall survival and 20% better lung cancer-specific survival than those who had never been diagnosed with another cancer before getting lung cancer.
Link to the complete report on Medline Plus: http://1.usa.gov/1EJzIEO
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
